to Improve the Effectiveness of a Amino Acid Dietary Supplement in Chronic Pharyngeal Infections vs Placebo Clinical Trial
Official title:
Amino Acid Composition Reduces Frequency of Common Cold. Results of a Controlled Randomized Completely Masked Trial
| Verified date | August 2011 |
| Source | Kyberg Vital GmbH |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Germany: Ethics Commission |
| Study type | Interventional |
The purpose of this study is to investigate the effectiveness of a dietary supplement with high dosage of amino acids and vitamins in the treatment of acute and chronic infection of pharyngeal area known as common cold. T
| Status | Completed |
| Enrollment | 145 |
| Est. completion date | September 2010 |
| Est. primary completion date | February 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years to 70 Years |
| Eligibility |
Inclusion Criteria: men and women with at least two episodes of common cold and infection of ear, nose and pharyngeal area. Exclusion Criteria: - people with severe infection like pneumonia, patients expecting an in-patient treatment during the trial, pregnant or breast feeding and people not able to understand the procedure of the treatment |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Germany | Kyberg Vital - Doris Meister | Oberhaching | Bavaria |
| Lead Sponsor | Collaborator |
|---|---|
| Kyberg Vital GmbH |
Germany,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | outcome of efficacy | For each study day,participants recorded in a diary rectal temperature, symptoms of sneezing, blocked nose or streaming eyes, whether they had problems to swollow and whether they had headache or pain in arms or legs. | 3 month treatment | No |
| Secondary | outcome of efficacy | Secondary outcome variables: feel the patient fit and able-bodied. | 3 month treatment | No |